Menu
Not yet recruiting NCT07274150

Abdominal Aortic Junction Tourniquet (AAJT-S) for Non-compressible Torso Haemorrhage in the Prehospital and Emergency Room Setting

Observational Exanguination Polytrauma NCTH

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Exanguination, Polytrauma, NCTH. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Austria
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Abdominal Aortic Junction Tourniquet (AAJT-S) for Non-compressible Torso Haemorrhage A Prospective Multicentre-study

Overview

This study seeks to evaluate the feasibility of a Abdominal Aortic Balloon Occlusion of the Aorta (AAJT-S) in exanguinating trauma patients with non-compressible truncal haemorrhage in the emergency room and the pre-hospital setting.

Detailed description

Much like REBOA, AAJT-S can potentially stop blood flow distal to the device and therefore improve proximal aortic perfusion, minimize haemorrhage and stabilize patients until definite surgical repair/bleeding control is feasible. In contrast to REBOA, there is no need of femoral access and therefore, appropriate training is easily achieved.

This study seeks to gather further information on the benefits and potential harms of this intervention on a multicentre level.

Primary outcome measures

  • effective placement of the device [Time frame: 1 hour]
Secondary outcome measures (3)
  • Outcome Measure [Time frame: 30 days]
  • Complications [Time frame: 90 days]
  • hemodynamic improvement after application [Time frame: 1 hour]

Eligibility criteria

Inclusion criteria

  • Written consent of the participant after being informed
  • Aged, or believed to be aged, 18 years or above
  • Confirmed or suspected life-threatening lower body trauma (i.e. signs of inadequate perfusion of tissues, tachycardia, hypotension, suspected blood loss)
  • Thought to benefit from trauma resuscitation with AAJT-S or REBOA zone III
  • Traumatic cardiac arrest

Exclusion criteria

\-

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

Austria · 1 center
  • Medical University of Graz — Graz

Identifiers

NCT: NCT07274150 · 1331/2025

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗